Equity
€403,348 from €764,341 in 2020
Equity fell by 47% in 5 years.
ECOPHARMASUPPLY DISTRIBUTION
Lifetime
19 annual accounts with figures on one time axis, 30 filings since 1996Gross marginpeak €386,166 (2021)
€37,492▼ 54.3%
Resultlowest -€48,447 (2017)
€8,747▼ 79.4%
Equitypeak €764,341 (2020)
€403,348▲ 2.2%
Debts
€217,481▲ 54.5%
Staffpeak 3.3 FTE (2010)
-not published
Board8 names since 2017
2 directorsEllie SRL and 1 other
Owners6 names in the annual accounts
100%MEDIGROUP and 1 other
Documentsfilings and deeds
29-06-202632 days before the deadline
2025financial year
Gross margin from €82,119 to €37,492Result from €42,370 to €8,7471 director appointed, 2 resignations 30-103 directors reappointed, 1 statutory auditor reappointed 15-09Debts from €140,776 to €217,481Cash from €16,744 to €5,838
Key points
from the 2025 annual accountsChecked score
92
Excellent
Financially stronger than 52% of micro companies in wholesale trade (NACE 46)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.4% across 26,896 companies (NACE 46, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%lowest value
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.2%▲ +0.1 percentage points vs 06-2025
08-2025: 0.1%▼ -0.1 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.3%▲ +0.2 percentage points vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026highest value
10-2026: 0.1%▼ -0.2 percentage points vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
Liquidity: current ratio 2.59, cash €5,838, halved
lowers risk
Founded in 1994
Size: total assets €620,829
Figures for financial year 2025 (filed on 29-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 71% of them on solvency, 33% on liquidity, 54% on profitability and 48% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 14,766 companies had the same profile as ECOPHARMASUPPLY DISTRIBUTION has now. Each dot stands for 37 companies, two years later.
96.2%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of ECOPHARMASUPPLY DISTRIBUTION itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,766 companies, not a prediction for ECOPHARMASUPPLY DISTRIBUTION. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.59 (3.18 in 2024), above the usual 1.5. Short-term debt is 35% and cash 0.9% of total assets. 35% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year €403,348
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 days early
2024
22 days early
2023
26 days early
2022
8 days late
2021
30 days early
2020
32 days early
2019
1 day early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 July (3 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
EB
EY Bedrijfsrevisoren BV
Auditor, Wouter Robyns
- MEDIGROUP 100%score 91equity €23.7m (2025) · 2025 annual accounts of MEDIGROUP
- ELLIE 50.04%score 96equity €496,545 (2025) · 2021 annual accounts of ELLIE
- Abacus Medicine A/S consolidatesannual accounts 2025
Recent changes
New statutory auditor
EY Bedrijfsrevisoren BV appointed, Deloitte Bedrijfsrevisoren resigned · General meeting of 26-06-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0453405120
1 director appointed, 2 resignations
Resignations: Themtis BV and LMDC GmbH · Appointment: Jordan Chir · Permanent representative: Libor Matyasek · General meeting of 29-09-2025 · Gazette deed
3 directors reappointed, 1 statutory auditor reappointed
Ellie SRL, Themtis SRL, LMDC GmbH and Deloitte Bedrijfsrevisoren SRL (statutory auditor) · Permanent representatives: Grégory Tjoens, Filip Van de Vliet and Libor Matyasek · General meeting of 30-06-2025 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | Total assets | Gross margin | Solvency | Staff |
|---|---|---|---|---|
| ECOPHARMASUPPLY DISTRIBUTION Estaimpuis | €620,829 | €37,492 | 65.0% | - |
| ADOCS Machelen (Brab.) | €717,403 | €45,936 | 66.4% | - |
| MEDICAL CARE SYSTEMS Gingelom | €501,640 | €34,697 | 93.1% | - |
| IMMO VITA Braine-l'Alleud | €609,667 | €26,076 | -5.2% | - |
| Meditron Sint-Gillis-Waas | €488,085 | €33,734 | 88.9% | - |
| DUBOIS MEDICA Bilzen-Hoeselt | €534,200 | €49,256 | 72.7% | - |
| PATRIMOL Stekene | €619,408 | €29,592 | 19.3% | - |
These companies have the same main activity as ECOPHARMASUPPLY DISTRIBUTION: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €488,000 and €717,000, founded between 1988 and 1997.
Official details
Source: KBO- Status
- Active since 08-09-1994Normal situation
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460and 8 others
- Establishment units
- 2.071.375.6127700 Mouscron, since 02-05-1995
- 2.302.074.3737730 Estaimpuis, since 11-05-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 29-12-2025
Annual accounts 2025
- Total assets
- €620,829▲ 16.0%
- Filing
- Filed on 29-06-2026, 32 days before the end of the filing period
Companies linked to ECOPHARMASUPPLY DISTRIBUTION
Parent and group
Shareholders
- ELYS CONSULT49.97%
Insights on ECOPHARMASUPPLY DISTRIBUTION
ECOPHARMASUPPLY DISTRIBUTION has existed since 1994. In 2021 the gross margin rose from €76,475 to €386,166.
Solvency fell in 2025 from 73.7% to 65.0% because of higher debts to suppliers.
MEDIGROUP holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ECOPHARMASUPPLY DISTRIBUTION
- What is the company number of ECOPHARMASUPPLY DISTRIBUTION?
- The company number of ECOPHARMASUPPLY DISTRIBUTION is 0453.405.120. The VAT number is the same number with BE in front: BE 0453.405.120.
- Where is ECOPHARMASUPPLY DISTRIBUTION based?
- The registered office is at Porte des Bâtisseurs 18, 7730 Estaimpuis.Company details
- What does ECOPHARMASUPPLY DISTRIBUTION do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of ECOPHARMASUPPLY DISTRIBUTION?
- ECOPHARMASUPPLY DISTRIBUTION is a public limited company (NV).
- When was ECOPHARMASUPPLY DISTRIBUTION founded?
- ECOPHARMASUPPLY DISTRIBUTION was founded on 08-09-1994.
- Is ECOPHARMASUPPLY DISTRIBUTION still active?
- Yes, ECOPHARMASUPPLY DISTRIBUTION is an active enterprise in the KBO register.
- What is the turnover of ECOPHARMASUPPLY DISTRIBUTION?
- The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €37,492 and 33 comparable companies (NACE 464). It probably lies between €120,000 and €390,000.Financials
- Is ECOPHARMASUPPLY DISTRIBUTION profitable?
- In financial year 2025, ECOPHARMASUPPLY DISTRIBUTION made a profit of €8,747.
- Where can I find the annual accounts of ECOPHARMASUPPLY DISTRIBUTION?
- ECOPHARMASUPPLY DISTRIBUTION filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ECOPHARMASUPPLY DISTRIBUTION due?
- ECOPHARMASUPPLY DISTRIBUTION must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See the other companies in the same group.A.forall Group · 9 companies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.